Research Archive — Page 120 of 131
-
August 3, 2016
Fetal impact of antidepressants
Antidepressant use during pregnancy is common. Fetal exposure to the class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) is associated with the life-threatening condition PPHN (persistent pulmonary hypertension of the newborn), but a causal link has not been established. -
July 28, 2016
Marrow cells’ role in pulmonary hypertension explored
Cells from the bone marrow participate in the development of pulmonary arterial hypertension (PAH), and they can also protect against it, according to new findings from a team of Vanderbilt University Medical Center investigators. -
June 6, 2016
Pulmonary fibrosis culprits
New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease. -
June 2, 2016
New software tracks cancer mutations, survival
A team at Vanderbilt University Medical Center (VUMC) has developed and tested software that scans electronic health records in real time to monitor cancer patient survival (from time of diagnosis) according to which genes, if any, are found to carry mutations. -
May 17, 2016
Study finds menthol cigarettes do not further increase smokers’ cardiovascular disease, stroke risk
Smoking is deleterious to health, but smokers who prefer menthol cigarettes to nonmenthol can breathe a sigh of relief…for now. -
April 28, 2016
Study sheds light on link between autism, GI issues
Researchers at Columbia and Vanderbilt universities have made an important discovery in mice that has implications for understanding the gastrointestinal (GI) problems experienced by some children with autism. -
April 28, 2016
Vanderbilt Prize lecture details ‘Goldilocks Principle’
When it comes to the brain, levels of molecules involved in neuronal signaling must be “just right,” or things can go terribly wrong.